More News

08 Jul 2019 Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
08 Jul 2019 Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
08 Jul 2019 Eisai enters into collaboration research agreement with University of Dundee on targeted protein degradation toward cancer drug discovery
03 Jul 2019 Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)
03 Jul 2019 New partnership to advance Nosopharm’s lead candidate to clinical stage and develop second drug candidate
03 Jul 2019 Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds
02 Jul 2019 Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
01 Jul 2019 PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
01 Jul 2019 Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation
01 Jul 2019 PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis
27 Jun 2019 Seelos Therapeutics Announces Acquisition of an Exclusive Worldwide License of Gene Therapy Program to Address Parkinson’s Disease from Duke University
27 Jun 2019 ImmunoGen Announces Completion of Operational Review
27 Jun 2019 OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
25 Jun 2019 AbbVie to Acquire Allergan in Transformative Move for Both Companies
25 Jun 2019 ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies
25 Jun 2019 C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline
25 Jun 2019 Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
25 Jun 2019 Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
21 Jun 2019 Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
20 Jun 2019 Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
20 Jun 2019 Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
20 Jun 2019 Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership
19 Jun 2019 Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine
17 Jun 2019 Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
17 Jun 2019 Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up